{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T13:40:54Z","timestamp":1791726054275,"version":"4.3.4"},"reference-count":106,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,6]],"date-time":"2024-03-06T00:00:00Z","timestamp":1709683200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","ijidonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.ijid.2024.107002","type":"journal-article","created":{"date-parts":[[2024,3,11]],"date-time":"2024-03-11T12:37:23Z","timestamp":1710160643000},"page":"107002","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"S","title":["Screening for latent tuberculosis in migrants\u2014status quo and future challenges"],"prefix":"10.1016","volume":"141","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8510-0614","authenticated-orcid":false,"given":"Eskild","family":"Petersen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2669-6814","authenticated-orcid":false,"given":"Seif","family":"Al-Abri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amina","family":"Al-Jardani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziad A.","family":"Memish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9788-0790","authenticated-orcid":false,"given":"Eleni","family":"Aklillu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4748-050X","authenticated-orcid":false,"given":"Francine","family":"Ntoumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Mwaba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Wejse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alimuddin","family":"Zumla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatma","family":"Al-Yaquobi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijid.2024.107002_bib0001","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00655-2019","article-title":"The global prevalence of latent tuberculosis: a systematic review and meta-analysis","volume":"54","author":"Cohen","year":"2019","journal-title":"Eur Respir J"},{"issue":"23","key":"10.1016\/j.ijid.2024.107002_bib0002","first-page":"00533","article-title":"Tuberculosis prevention: current strategies and future directions","volume":"S1198-743X","author":"Vasiliu","year":"2023","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijid.2024.107002_bib0003","unstructured":"World Health Organization. Global tuberculosis report 2023. https:\/\/reliefweb.int\/report\/world\/global-tuberculosis-report-2023. [accessed 4 February 2024]."},{"issue":"3","key":"10.1016\/j.ijid.2024.107002_bib0004","doi-asserted-by":"crossref","first-page":"190","DOI":"10.5588\/ijtld.21.0753","article-title":"Clinical standards for the diagnosis, treatment and prevention of TB infection","volume":"26","author":"Migliori","year":"2022","journal-title":"Int J Tuberc Lung Dis"},{"issue":"5","key":"10.1016\/j.ijid.2024.107002_bib0005","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01786-2021","article-title":"Gauging the impact of the COVID-19 pandemic on tuberculosis services: a global study","volume":"58","author":"Migliori","year":"2021","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ijid.2024.107002_bib0006","unstructured":"International Organization for Migration, IOM. World migration report 2022. https:\/\/reliefweb.int\/report\/world\/world-migration-report-2022. [accessed 4 February 2024]."},{"key":"10.1016\/j.ijid.2024.107002_bib0007","unstructured":"United Nations Refugee Agency, UNHCR. Global report 2022. https:\/\/reporting.unhcr.org\/global-report-2022. [accessed 4 February 2024]."},{"key":"10.1016\/j.ijid.2024.107002_bib0008","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/s12879-023-08098-y","article-title":"Time to diagnosis and treatment of pulmonary tuberculosis in indigenous peoples: a systematic review","volume":"23","author":"Varughese","year":"2023","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.ijid.2024.107002_bib0009","doi-asserted-by":"crossref","first-page":"182","DOI":"10.5588\/ijtld.22.0662","article-title":"Reducing the burden of TB among migrants to low TB incidence countries","volume":"27","author":"Spruijt","year":"2023","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.ijid.2024.107002_bib0010","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1004030","article-title":"Mandatory, voluntary, repetitive, or one-off post-migration follow-up for tuberculosis prevention and control: a systematic review","volume":"20","author":"Wahedi","year":"2023","journal-title":"PLoS Med"},{"key":"10.1016\/j.ijid.2024.107002_bib0011","unstructured":"United Nations Refugee Agency, UNHCR. Who we protect: refugees. https:\/\/www.unhcr.org\/about-unhcr\/who-we-protect\/refugees. [accessed 5 February 2024]."},{"key":"10.1016\/j.ijid.2024.107002_bib0012","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1016\/S1473-3099(23)00372-9","article-title":"Burden of tuberculosis among vulnerable populations worldwide: an overview of systematic reviews","volume":"23","author":"Litvinjenko","year":"2023","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijid.2024.107002_bib0013","doi-asserted-by":"crossref","first-page":"taac136","DOI":"10.1093\/jtm\/taac136","article-title":"National policies for delivering tuberculosis, HIV and hepatitis B and C virus infection services for refugees and migrants among Member States of the WHO European Region","volume":"30","author":"Baggaley","year":"2023","journal-title":"J Travel Med"},{"key":"10.1016\/j.ijid.2024.107002_bib0014","doi-asserted-by":"crossref","DOI":"10.1016\/j.tmaid.2023.102568","article-title":"World tuberculosis day 2023\u2014reflections on the spread of drug-resistant tuberculosis by travellers and reducing risk in forcibly displaced populations","volume":"53","author":"Rodriguez-Morales","year":"2023","journal-title":"Travel Med Infect Dis"},{"key":"10.1016\/j.ijid.2024.107002_bib0015","doi-asserted-by":"crossref","first-page":"21","DOI":"10.5588\/ijtld.22.0654","article-title":"Cost-effectiveness of expanded latent TB infection testing and treatment: Lynn City, Massachusetts, USA","volume":"28","author":"Beeler Asay","year":"2024","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.ijid.2024.107002_bib0016","article-title":"Finding and treating both tuberculosis disease and latent infection during population-wide active case finding for tuberculosis elimination","volume":"10","author":"Coleman","year":"2023","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.ijid.2024.107002_bib0017","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1186\/s12889-021-12142-4","article-title":"Targeting screening and treatment for latent tuberculosis infection towards asylum seekers from high-incidence countries\u2014a model-based cost-effectiveness analysis","volume":"21","author":"Marx","year":"2021","journal-title":"BMC Public Health"},{"key":"10.1016\/j.ijid.2024.107002_bib0018","doi-asserted-by":"crossref","first-page":"2390","DOI":"10.1038\/s41598-023-29648-z","article-title":"A cost-effectiveness evaluation of latent tuberculosis infection screening of a migrant population in Malaysia","volume":"13","author":"Barker","year":"2023","journal-title":"Sci Rep"},{"key":"10.1016\/j.ijid.2024.107002_bib0019","doi-asserted-by":"crossref","first-page":"286","DOI":"10.15585\/mmwr.mm6911a3","article-title":"Tuberculosis\u2014United States, 2019","volume":"69","author":"Schwartz","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.ijid.2024.107002_bib0020","unstructured":"Centers for Disease Control and Prevention. Reported tuberculosis in the United States, 2018 https:\/\/www.cdc.gov\/tb\/statistics\/reports\/2018\/national_data.htm. [accessed 10 February 2024]."},{"key":"10.1016\/j.ijid.2024.107002_bib0021","unstructured":"European Center for Disease Control, ECDC. Tuberculosis surveillance and monitoring in Europe, 2023. https:\/\/www.ecdc.europa.eu\/sites\/default\/files\/documents\/tuberculosis-surveillance-monitoring-2023.pdf. [accessed 5 February 2024]."},{"key":"10.1016\/j.ijid.2024.107002_bib0022","doi-asserted-by":"crossref","first-page":"39","DOI":"10.5588\/ijtld.23.0292","article-title":"Increasing incidence of TB in a low burden TB country due to migration from Ukraine","volume":"28","author":"Dole\u017ealov\u00e1","year":"2024","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.ijid.2024.107002_bib0023","doi-asserted-by":"crossref","first-page":"624","DOI":"10.5588\/ijtld.16.0845","article-title":"Tuberculosis in migrants in low-incidence countries: epidemiology and intervention entry points","volume":"21","author":"L\u00f6nnroth","year":"2017","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.ijid.2024.107002_bib0024","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0268696","article-title":"Tuberculosis among refugees and migrant populations: systematic review","volume":"17","author":"Meaza","year":"2022","journal-title":"PLoS One"},{"issue":"23","key":"10.1016\/j.ijid.2024.107002_bib0025","first-page":"00340","article-title":"Update on the diagnosis of tuberculosis","volume":"S1198-743X","author":"Kontsevaya","year":"2023","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijid.2024.107002_bib0026","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/S1473-3099(23)00371-7","article-title":"Incidence and risk factors of tuberculosis among 420 854 household contacts of patients with tuberculosis in the 100 Million Brazilian Cohort (2004-18): a cohort study","volume":"24","author":"Pinto","year":"2024","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijid.2024.107002_bib0027","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0127-2022","article-title":"A scoping review on the risk of tuberculosis in specific population groups: can we expand the World Health Organization recommendations?","volume":"32","author":"Bigio","year":"2023","journal-title":"Eur Respir Rev"},{"key":"10.1016\/j.ijid.2024.107002_bib0028","unstructured":"World Health Organization. Latent tuberculosis infection: updated and consolidated guidelines for programmatic management https:\/\/www.who.int\/publications\/i\/item\/9789241550239; 2018 [accessed 4 February 2024]."},{"key":"10.1016\/j.ijid.2024.107002_bib0029","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1016\/S1473-3099(21)00052-9","article-title":"Initiation and completion of treatment for latent tuberculosis infection in migrants globally: a systematic review and meta-analysis","volume":"21","author":"Rustage","year":"2021","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijid.2024.107002_bib0030","doi-asserted-by":"crossref","first-page":"4195","DOI":"10.1128\/IAI.69.7.4195-4201.2001","article-title":"Tuberculosis: latency and reactivation","volume":"69","author":"Flynn","year":"2001","journal-title":"Infect Immun"},{"key":"10.1016\/j.ijid.2024.107002_bib0031","doi-asserted-by":"crossref","first-page":"284","DOI":"10.5588\/ijtld.22.0685","article-title":"Epidemiology, pathogenesis, clinical presentation and management of TB in patients with HIV and diabetes","volume":"27","author":"Goletti","year":"2023","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.ijid.2024.107002_bib0032","doi-asserted-by":"crossref","first-page":"e303","DOI":"10.1016\/S1473-3099(20)30728-3","article-title":"Quantifying the rates of late reactivation tuberculosis: a systematic review","volume":"21","author":"Dale","year":"2021","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijid.2024.107002_bib0033","article-title":"The definition of tuberculosis infection based on the spectrum of tuberculosis disease","volume":"17","author":"Migliori","year":"2021","journal-title":"Breathe (Sheff)"},{"key":"10.1016\/j.ijid.2024.107002_bib0034","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1097\/EDE.0000000000001707","article-title":"Estimated rates of progression to tuberculosis disease for persons infected with Mycobacterium tuberculosis in the United States","volume":"35","author":"Ekramnia","year":"2024","journal-title":"Epidemiology"},{"key":"10.1016\/j.ijid.2024.107002_bib0035","doi-asserted-by":"crossref","first-page":"e305","DOI":"10.1016\/S2468-2667(22)00031-7","article-title":"Effectiveness of nationwide programmatic testing and treatment for latent tuberculosis infection in migrants in England: a retrospective, population-based cohort study","volume":"7","author":"Berrocal-Almanza","year":"2022","journal-title":"Lancet Public Health"},{"key":"10.1016\/j.ijid.2024.107002_bib0036","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.03831-2020","article-title":"Screening for tuberculosis among high-risk groups attending London emergency departments: a prospective observational study","volume":"57","author":"Gupta","year":"2021","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ijid.2024.107002_bib0037","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s12916-016-0595-5","article-title":"The impact of migration on tuberculosis epidemiology and control in high-income countries: a review","volume":"14","author":"Pareek","year":"2016","journal-title":"BMC Med"},{"issue":"12","key":"10.1016\/j.ijid.2024.107002_bib0038","doi-asserted-by":"crossref","first-page":"E939","DOI":"10.1503\/cmaj.090302","article-title":"Tuberculosis: evidence review for newly arriving immigrants and refugees","volume":"183","author":"Greenaway","year":"2011","journal-title":"CMAJ"},{"key":"10.1016\/j.ijid.2024.107002_bib0039","first-page":"17","article-title":"The effectiveness and cost-effectiveness of screening for latent tuberculosis among migrants in the EU\/EEA: a systematic review","volume":"23","author":"Greenaway","year":"2018","journal-title":"Euro Surveill"},{"key":"10.1016\/j.ijid.2024.107002_bib0040","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1513\/AnnalsATS.201405-188OC","article-title":"Reproducibility of interferon gamma (IFN-\u03b3) release assays. A systematic review","volume":"11","author":"Tagmouti","year":"2014","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.ijid.2024.107002_bib0041","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1186\/s12890-022-02149-x","article-title":"A systematic review of cost-utility analyses of screening methods in latent tuberculosis infection in high-risk populations","volume":"22","author":"Mahon","year":"2022","journal-title":"BMC Pulm Med"},{"key":"10.1016\/j.ijid.2024.107002_bib0042","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1093\/aje\/kwt246","article-title":"Estimated rate of reactivation of latent tuberculosis infection in the United States, overall and by population subgroup","volume":"179","author":"Shea","year":"2014","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.ijid.2024.107002_bib0043","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/S1473-3099(17)30194-9","article-title":"Post-migration follow-up of migrants identified to be at increased risk of developing tuberculosis at pre-migration screening: a systematic review and meta-analysis","volume":"17","author":"Chan","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijid.2024.107002_bib0044","doi-asserted-by":"crossref","first-page":"2510","DOI":"10.1016\/S0140-6736(16)31008-X","article-title":"Tuberculosis in migrants moving from high-incidence to low-incidence countries: a population-based cohort study of 519,955 migrants screened before entry to England, Wales, and Northern Ireland","volume":"388","author":"Aldridge","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.ijid.2024.107002_bib0045","unstructured":"World Health Organization. Use of alternative interferon-gamma release assays for the diagnosis of TB infection - WHO Policy Statement. www.who.int\/news\/item\/28-01-2022-use-of-alternative-interferon-gamma-release-assays-for-the-diagnosis-of-tb-infection; 2022 [accessed 5 February 2024]."},{"key":"10.1016\/j.ijid.2024.107002_bib0046","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1001\/jama.2023.4899","article-title":"Screening for latent tuberculosis infection in adults: US Preventive Services Task Force Recommendation Statement","volume":"329","year":"2023","journal-title":"JAMA"},{"key":"10.1016\/j.ijid.2024.107002_bib0047","doi-asserted-by":"crossref","first-page":"661","DOI":"10.3201\/eid2504.171630","article-title":"Cost-effectiveness of latent tuberculosis infection screening before immigration to low-incidence countries","volume":"25","author":"Campbell","year":"2019","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.ijid.2024.107002_bib0048","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1006\/pmed.2000.0654","article-title":"No evidence for multiple-drug prophylaxis for tuberculosis compared with isoniazid alone in Southeast Asian refugees and migrants: completion and compliance are major determinants of effectiveness","volume":"30","author":"MacIntyre","year":"2000","journal-title":"Prev Med"},{"key":"10.1016\/j.ijid.2024.107002_bib0049","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1001\/jama.1997.03540330057035","article-title":"Tuberculosis among Tibetan immigrants from India and Nepal in Minnesota, 1992-1995","volume":"277","author":"Truong","year":"1997","journal-title":"JAMA"},{"key":"10.1016\/j.ijid.2024.107002_bib0050","doi-asserted-by":"crossref","DOI":"10.1136\/thoraxjnl-2017-211147","article-title":"Stratification by interferon-\u03b3 release assay level predicts risk of incident TB","author":"Winje","year":"2018","journal-title":"Thorax"},{"key":"10.1016\/j.ijid.2024.107002_bib0051","first-page":"1209","article-title":"Predictive values of QuantiFERON-TB Gold testing in screening for tuberculosis disease in asylum seekers","volume":"14","author":"Harstad","year":"2010","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.ijid.2024.107002_bib0052","doi-asserted-by":"crossref","first-page":"965","DOI":"10.5588\/ijtld.16.0935","article-title":"Effectiveness and cost-effectiveness of screening migrants for active tuberculosis and latent tuberculous infection","volume":"21","author":"Zenner","year":"2017","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.ijid.2024.107002_bib0053","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/s12879-019-3745-5","article-title":"Predictors of discordant latent tuberculosis infection test results amongst South African health care workers","volume":"19","author":"Adams","year":"2019","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.ijid.2024.107002_bib0054","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0188631","article-title":"Interferon-gamma release assay for the diagnosis of latent tuberculosis infection: a latent-class analysis","volume":"12","author":"Doan","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.ijid.2024.107002_bib0055","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2021-054663","article-title":"Tuberculosis infection in children and adolescents: testing and treatment","volume":"148","author":"Nolt","year":"2021","journal-title":"Pediatrics"},{"key":"10.1016\/j.ijid.2024.107002_bib0056","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0295913","article-title":"QuantiFERON Gold-In-Tube for the diagnosis of mycobacterial tuberculosis infection in children under 5 years of age: a systematic review and meta-analysis","volume":"19","author":"Volkman","year":"2024","journal-title":"PLoS One"},{"key":"10.1016\/j.ijid.2024.107002_bib0057","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1080\/14737159.2023.2240230","article-title":"Research tests for the diagnosis of tuberculosis infection","volume":"23","author":"Alonzi","year":"2023","journal-title":"Expert Rev Mol Diagn"},{"key":"10.1016\/j.ijid.2024.107002_bib0058","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2023-012297","article-title":"A costing framework to compare tuberculosis infection tests","volume":"8","author":"Brumwell","year":"2023","journal-title":"BMJ Glob Health"},{"key":"10.1016\/j.ijid.2024.107002_bib0059","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.jmii.2023.07.014","article-title":"Predicting stringent QuantiFERON-TB Gold Plus conversions in contacts of tuberculosis patients","volume":"56","author":"Pan","year":"2023","journal-title":"J Microbiol Immunol Infect"},{"issue":"Suppl 1","key":"10.1016\/j.ijid.2024.107002_bib0060","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1016\/j.ijid.2022.02.047","article-title":"The role of IGRA in the diagnosis of tuberculosis infection, differentiating from active tuberculosis, and decision making for initiating treatment or preventive therapy of tuberculosis infection","volume":"124","author":"Goletti","year":"2022","journal-title":"Intl J Infect Dis"},{"key":"10.1016\/j.ijid.2024.107002_bib0061","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0156917","article-title":"Comparison of the sensitivity of QuantiFERON-TB Gold In-Tube and T-SPOT.TB according to patient age","volume":"11","author":"Bae","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.ijid.2024.107002_bib0062","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2021-057717","volume":"12","author":"Rangaka","year":"2022","journal-title":"BMJ Open"},{"key":"10.1016\/j.ijid.2024.107002_bib0063","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1378\/chest.11-3157","article-title":"Predictive value of interferon-\u03b3 release assays and tuberculin skin testing for progression from latent TB infection to disease state: a meta-analysis","volume":"142","author":"Diel","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.ijid.2024.107002_bib0064","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1183\/09031936.00115110","article-title":"Interferon-\u03b3 release assays for the diagnosis of latent Mycobacterium tuberculosis infection: a systematic review and meta-analysis","volume":"37","author":"Diel","year":"2011","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ijid.2024.107002_bib0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2022.101815","article-title":"Predictive performance of interferon-gamma release assays and the tuberculin skin test for incident tuberculosis: an individual participant data meta-analysis","volume":"56","author":"Hamada","year":"2023","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.ijid.2024.107002_bib0066","doi-asserted-by":"crossref","first-page":"453","DOI":"10.3390\/diagnostics12020453","article-title":"Diagnostic value of interferon-gamma release assays for tuberculosis in the immunocompromised population","volume":"12","author":"Yang","year":"2022","journal-title":"Diagnostics (Basel)"},{"issue":"23","key":"10.1016\/j.ijid.2024.107002_bib0067","article-title":"Effect of a latent tuberculosis infection programme for healthcare workers in a country with an intermediate tuberculosis burden","volume":"S0195-6701","author":"Cho","year":"2023","journal-title":"J Hosp Infect"},{"key":"10.1016\/j.ijid.2024.107002_bib0068","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1093\/cid\/ciad245","article-title":"Scale-up of rifapentine and isoniazid for tuberculosis prevention among household contacts in 2 urban centers: an effectiveness assessment","volume":"77","author":"Hussain","year":"2023","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2024.107002_bib0069","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01226-2017","article-title":"National roll-out of latent tuberculosis testing and treatment for new migrants in England: a retrospective evaluation in a high-incidence area","volume":"51","author":"Loutet","year":"2018","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ijid.2024.107002_bib0070","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1186\/s12879-016-1550-y","article-title":"Initiation and completion rates for latent tuberculosis infection treatment: a systematic review","volume":"16","author":"Sandgren","year":"2016","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.ijid.2024.107002_bib0071","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2021-050629","article-title":"Cross-sectional study of prevalence and risk factors, and a cost-effectiveness evaluation of screening and preventive treatment strategies for latent tuberculosis among migrants in Singapore","volume":"11","author":"Lim","year":"2021","journal-title":"BMJ Open"},{"key":"10.1016\/j.ijid.2024.107002_bib0072","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2022-070813","article-title":"Healthcare professionals' intention to adopt mobile phone-based SMS and its predictors for adherence support and care of TB patients in a resource-limited setting: a structural equation modelling analysis","volume":"13","author":"Walle","year":"2023","journal-title":"BMJ Open"},{"key":"10.1016\/j.ijid.2024.107002_bib0073","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1186\/s12879-023-08612-2","article-title":"Facilitators and barriers for tuberculosis preventive treatment among patients with latent tuberculosis infection: a qualitative study","volume":"23","author":"Manoharan","year":"2023","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.ijid.2024.107002_bib0074","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1093\/cid\/ciz817","article-title":"Determinants of latent tuberculosis treatment acceptance and completion in healthcare personnel","volume":"71","author":"Swift","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2024.107002_bib0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.cct.2023.107173","article-title":"Using a medication event monitoring system to evaluate self-report and pill count for determining treatment completion with self-administered, once-weekly isoniazid and rifapentine","volume":"129","author":"Scott","year":"2023","journal-title":"Contemp Clin Trials"},{"key":"10.1016\/j.ijid.2024.107002_bib0076","doi-asserted-by":"crossref","first-page":"6462","DOI":"10.1038\/s41598-020-63156-8","article-title":"Adherence to nine-month isoniazid for latent tuberculosis infection in healthcare workers: a prospective study in a tertiary hospital","volume":"10","author":"Chung","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.ijid.2024.107002_bib0077","unstructured":"UK Govt Guidance. Latent tuberculosis testing and treatment programme for migrants https:\/\/www.gov.uk\/government\/publications\/latent-tuberculosis-testing-and-treatment-programme-for-migrants; 2021 [accessed 10 February 2024]."},{"key":"10.1016\/j.ijid.2024.107002_bib0078","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1186\/s12913-020-05220-7","article-title":"Resource implications of the latent tuberculosis cascade of care: a time and motion study in five countries","volume":"20","author":"Alsdurf","year":"2020","journal-title":"BMC Health Serv Res"},{"key":"10.1016\/j.ijid.2024.107002_bib0079","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s13690-023-01098-z","article-title":"Efficacy and safety of different regimens in the treatment of patients with latent tuberculosis infection: a systematic review and network meta-analysis of randomized controlled trials","volume":"81","author":"Assefa","year":"2023","journal-title":"Arch Public Health"},{"key":"10.1016\/j.ijid.2024.107002_bib0080","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1186\/s12879-016-1549-4","article-title":"Interventions for improving adherence to treatment for latent tuberculosis infection: a systematic review","volume":"16","author":"Stuurman","year":"2016","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.ijid.2024.107002_bib0081","unstructured":"European Center for Disease Control, ECDC. Migrants in an irregular situation: access to healthcare in 10 European Union Member States. https:\/\/fra.europa.eu\/sites\/default\/files\/fra_uploads\/1771-FRA-2011-fundamental-rights-for-irregular-migrants-healthcare_EN.pdf; 2011 [accessed 5 February 2024]."},{"key":"10.1016\/j.ijid.2024.107002_bib0082","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1353\/hpu.2015.0126","article-title":"Improving treatment completion rates for latent tuberculosis infection: a review of two treatment regimens at a community health center","volume":"26","author":"Lines","year":"2015","journal-title":"J Health Care Poor Underserved"},{"key":"10.1016\/j.ijid.2024.107002_bib0083","doi-asserted-by":"crossref","first-page":"942","DOI":"10.5588\/ijtld.22.0186","article-title":"Country differences and determinants of yield in programmatic migrant TB screening in four European countries","volume":"26","author":"Menezes","year":"2022","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.ijid.2024.107002_bib0084","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1056\/NEJMoa1714283","article-title":"Four months of rifampin or nine months of isoniazid for latent tuberculosis in adults","volume":"379","author":"Menzies","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijid.2024.107002_bib0085","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1186\/s12879-017-2377-x","article-title":"Efficacy and completion rates of rifapentine and isoniazid (3HP) compared to other treatment regimens for latent tuberculosis infection: a systematic review with network meta-analyses","volume":"17","author":"Pease","year":"2017","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.ijid.2024.107002_bib0086","unstructured":"Tuberculosis preventive treatment: rapid communication. https:\/\/www.who.int\/publications\/i\/item\/9789240089723 [accessed 14 February 2024]."},{"key":"10.1016\/j.ijid.2024.107002_bib0087","series-title":"Int J Infect Dis.","first-page":"S72","article-title":"Cost-effectiveness of IGRA\/QFT-Plus for TB screening of migrants in Oman","author":"Al Abri","year":"2020"},{"key":"10.1016\/j.ijid.2024.107002_bib0088","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/QAD.0000000000003060","article-title":"Cost-effectiveness of testing for latent tuberculosis infection in people with HIV","volume":"36","author":"Auguste","year":"2022","journal-title":"AIDS"},{"key":"10.1016\/j.ijid.2024.107002_bib0089","doi-asserted-by":"crossref","first-page":"13529","DOI":"10.3390\/ijerph192013529","article-title":"Economic evaluation of screening strategy for latent tuberculosis infection (LTBI) in contacts of tuberculosis patients: systematic review and quality assessment","volume":"19","author":"Yoopetch","year":"2022","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.ijid.2024.107002_bib0090","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.vhri.2023.11.010","article-title":"Cost-effectiveness analysis comparing QuantiFERON-TB Gold plus test and tuberculin skin test for the diagnosis of latent tuberculosis infection in immunocompetent subjects in Colombia","volume":"41","author":"Navarro","year":"2024","journal-title":"Value Health Reg Issues"},{"key":"10.1016\/j.ijid.2024.107002_bib0091","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1186\/s12913-022-08855-w","article-title":"\"It's too hard\"\u2014the management of latent TB in under-served populations in the UK: a qualitative study","volume":"22","author":"Gray","year":"2022","journal-title":"BMC Health Serv Res"},{"issue":"10","key":"10.1016\/j.ijid.2024.107002_bib0092","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/S1473-3099(18)30355-4","article-title":"Prognostic value of interferon-\u03b3 release assays and tuberculin skin test in predicting the development of active tuberculosis (UK PREDICT TB): a prospective cohort study","volume":"18","author":"Abubakar","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijid.2024.107002_bib0093","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta22560","article-title":"Two interferon gamma release assays for predicting active tuberculosis: the UK PREDICT TB prognostic test study","volume":"22","author":"Abubakar","year":"2018","journal-title":"Health Technol Assess"},{"key":"10.1016\/j.ijid.2024.107002_bib0094","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1093\/aje\/kwab150","article-title":"Modeling the cost-effectiveness of latent tuberculosis screening and treatment strategies in recent migrants to a low-incidence setting","volume":"191","author":"Dale","year":"2022","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.ijid.2024.107002_bib0095","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.tmaid.2016.05.010","article-title":"Cost effectiveness of interferon-gamma release assay for tuberculosis screening using three months of rifapentine and isoniazid among long-term expatriates from low to high incidence countries","volume":"14","author":"Kowada","year":"2016","journal-title":"Travel Med Infect Dis"},{"key":"10.1016\/j.ijid.2024.107002_bib0096","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1183\/09031936.00155409","article-title":"Progress towards tuberculosis elimination: secular trend, immigration and transmission","volume":"36","author":"Borgdorff","year":"2010","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ijid.2024.107002_bib0097","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00591-2018","article-title":"Screening for tuberculosis in migrants and visitors from high-incidence settings: present and future perspectives","volume":"52","author":"Dobler","year":"2018","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ijid.2024.107002_bib0098","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0124116","article-title":"Cost-effectiveness of screening and treating foreign-born students for tuberculosis before entering the United States","volume":"10","author":"Wingate","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ijid.2024.107002_bib0099","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1080\/15265160902790583","article-title":"Screening in the dark: ethical considerations of providing screening tests to individuals when evidence is insufficient to support screening populations","volume":"9","author":"Burger","year":"2009","journal-title":"Am J Bioeth"},{"key":"10.1016\/j.ijid.2024.107002_bib0100","unstructured":"European Commission. Identifying serious and complex ethics issues in EU-funded research. https:\/\/ec.europa.eu\/info\/funding-tenders\/opportunities\/docs\/2021-2027\/horizon\/guidance\/guidelines-on-serious-and-complex-cases_he_en.pdf; 2021 [accessed 7 February 2024]."},{"key":"10.1016\/j.ijid.2024.107002_bib0101","unstructured":"International Organization for Migration, IOM. Migration & tuberculosis: a pressing issue. Health and development impacts of TB on migrants and communities. https:\/\/www.iom.int\/sites\/g\/files\/tmzbdl486\/files\/migrated_files\/What-We-Do\/docs\/Migration-Tuberculosis-A-Pressing-Issue.pdf; 2012 [accessed 7 February 2024]."},{"key":"10.1016\/j.ijid.2024.107002_bib0102","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1186\/s12889-022-13256-z","article-title":"Access to health services among culturally and linguistically diverse populations in the Australian universal health care system: issues and challenges","volume":"22","author":"Khatri","year":"2022","journal-title":"BMC Public Health"},{"key":"10.1016\/j.ijid.2024.107002_bib0103","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002595","article-title":"Adherence interventions and outcomes of tuberculosis treatment: a systematic review and meta-analysis of trials and observational studies","volume":"15","author":"Alipanah","year":"2018","journal-title":"PLoS Med"},{"key":"10.1016\/j.ijid.2024.107002_bib0104","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1007\/s10903-023-01475-4","article-title":"Factors associated with professional mental help-seeking among U.S. immigrants: a systematic review","volume":"25","author":"Mohammadifirouzeh","year":"2023","journal-title":"J Immigr Minor Health"},{"key":"10.1016\/j.ijid.2024.107002_bib0105","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s13012-019-0870-x","article-title":"Bridging the knowledge-practice gap in tuberculosis contact management in a high-burden setting: a mixed-methods protocol for a multicenter health system strengthening study","volume":"14","author":"Lestari","year":"2019","journal-title":"Implement Sci"},{"key":"10.1016\/j.ijid.2024.107002_bib0106","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1016\/S0140-6736(18)32114-7","article-title":"The UCL-Lancet Commission on Migration and Health: the health of a world on the move","volume":"392","author":"Abubakar","year":"2018","journal-title":"Lancet"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971224000730?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971224000730?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T06:30:48Z","timestamp":1730788248000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971224000730"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":106,"alternative-id":["S1201971224000730"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2024.107002","relation":{},"ISSN":["1201-9712"],"issn-type":[{"value":"1201-9712","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Screening for latent tuberculosis in migrants\u2014status quo and future challenges","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2024.107002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.","name":"copyright","label":"Copyright"}],"article-number":"107002"}}